Company intelligence / Profile preview

Southern Persistence

Ownership: Private
Employees: ~23000
Development stage: Other

Overview

Persistent Systems delivers technology-driven solutions to analytical instrument companies, medical device manufacturers, pharmaceutical firms, CROs and diagnostics organizations. It enables decentralized trials and connected labs through advanced software development. The company has supported 3 of the 5 largest CROs and 6 of the top 10 device manufacturers globally. Its healthcare/life sciences vertical generates nearly $400 million annualized revenue as of late 2024 with strong growth prospects.

Modalities: Small moleculeBiologicAntibody
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Partners with leading platform providers in cloud/data/AI/software sectors to deliver client projects in healthcare/life sciences domains.

Beyond the preview

Go deeper on Southern Persistence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Southern Persistence.

Explore the full profile